August 13, 2019

Edinburgh life sciences company acquired by leading player

Edinburgh-based Synpromics, a leader in gene control synthetic promoter technology, has been acquired by AskBio, a clinical stage and gene therapy platform company. Synpromics will operate as a wholly owned

OPEX data scientists
OPEX Group secures North Sea contract for digital services
Inoapps recruits new Chief Technical Officer
IoT Scotland seals first deal as Council introduces water monitoring technology
Phil Harris
Scottish engineering pioneer appoints new Chief Executive